Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9387)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Nov 28, 2022 (publication date) through Apr 21, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Li ZJ, Gou HZ, Zhang YL, Song XJ, Zhang L. Role of intestinal flora in primary sclerosing cholangitis and its potential therapeutic value. World J Gastroenterol 2022; 28(44): 6213-6229 [PMID: 36504550 DOI: 10.3748/wjg.v28.i44.6213] |
|---|---|
| URL: | https://www.wjgnet.com/2150-5330/full/v28/i44/6213.htm |
| Number | Citing Articles |
| 1 |
Sayantan Mukherjee, Aditi Chopra, Shaswata Karmakar, Subraya Giliyar Bhat. Periodontitis increases the risk of gastrointestinal dysfunction: an update on the plausible pathogenic molecular mechanisms. Critical Reviews in Microbiology 2025; 51(1): 187 doi: 10.1080/1040841X.2024.2339260
|
| 2 |
Ashraf Khalifa, Hairul Islam Mohamed Ibrahim, Abdullah Sheikh, Hany Ezzat Khalil. Probiotic-Fermented Camel Milk Attenuates Neurodegenerative Symptoms via SOX5/miR-218 Axis Orchestration in Mouse Models. Pharmaceuticals 2023; 16(3): 357 doi: 10.3390/ph16030357
|
| 3 |
Hui Hua, Qian-Qian Zhao, Miriam Nkesichi Kalagbor, Guo-Zhi Yu, Man Liu, Zheng-Rui Bian, Bei-Bei Zhang, Qian Yu, Yin-Hai Xu, Ren-Xian Tang, Kui-Yang Zheng, Chao Yan. Recombinant adeno-associated virus 8-mediated inhibition of microRNA let-7a ameliorates sclerosing cholangitis in a clinically relevant mouse model. World Journal of Gastroenterology 2024; 30(5): 471-484 doi: 10.3748/wjg.v30.i5.471
Abstract(463) |
Core Tip(517) |
Full Article(HTML)(1624)
|
Full Article with Cover (PDF)-11658K(172)
|
Full Article (Word)-4418K(15)
|
Audio-496K(5)
|
Peer-Review Report-310K(72)
|
Answering Reviewers-153K(71)
|
Supplementary Material-1111K(80)
|
Full Article (PDF)-8664K(130)
|
Full Article (XML)-152K(61)
|
Times Cited (0)
|
Total Visits (6980)
|
Open
|
| 4 |
Liping Li, Yongbo Kang. The Gut Microbiome and Autoimmune Hepatitis: Implications for Early Diagnostic Biomarkers and Novel Therapies. Molecular Nutrition & Food Research 2023; 67(24) doi: 10.1002/mnfr.202300043
|
| 5 |
Ludovico Abenavoli, Maria Luisa Gambardella, Giuseppe Guido Maria Scarlata, Ilaria Lenci, Leonardo Baiocchi, Francesco Luzza. The Many Faces of Metabolic Dysfunction-Associated Fatty Liver Disease Treatment: From the Mediterranean Diet to Fecal Microbiota Transplantation. Medicina 2024; 60(4): 563 doi: 10.3390/medicina60040563
|
| 6 |
Yushu Yang, XiaoSong He, Manuel Rojas, Patrick S. C. Leung, Lixia Gao. Mechanism-based target therapy in primary biliary cholangitis: opportunities before liver cirrhosis?. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1184252
|
| 7 |
Amala J. Alenchery, Sophia Patel, Lori Mahajan, Jacob A. Kurowski, Sarah Worley, Vera Hupertz, Kaddakal Radhakrishnan, Mohammad Nasser Kabbany. Single Center Experience of Oral Vancomycin Therapy in Young Patients with Primary Sclerosing Cholangitis: A Case Series. Livers 2023; 3(1): 93 doi: 10.3390/livers3010009
|
| 8 |
Xing Yu, Juan Guo, Meng Li Xue, Cheng Dang Wang, Wei Wei Zheng. Clinical Impact of Primary Sclerosing Cholangitis on Outcomes of Inflammatory Bowel Disease Hospitalization: A Propensity Score Matching Analysis of the Nationwide Inpatient Sample. Journal of Digestive Diseases 2025; doi: 10.1111/1751-2980.13339
|
| 9 |
Jessica Colin Escobar, Maria Navarez Pereyra, Mohammad Ali Abbass. Primary Sclerosing Cholangitis and Inflammatory Bowel Disease. Surgical Clinics of North America 2025; 105(2): 375 doi: 10.1016/j.suc.2024.11.001
|
| 10 |
Hoang Nam Pham, Linh Pham, Keisaku Sato. Navigating the liver landscape: upcoming pharmacotherapies for primary sclerosing cholangitis. Expert Opinion on Pharmacotherapy 2024; 25(7): 895 doi: 10.1080/14656566.2024.2362263
|
| 11 |
Beata Kasztelan-Szczerbinska, Anna Rycyk-Bojarzynska, Agnieszka Szczerbinska, Halina Cichoz-Lach. Selected Aspects of the Intricate Background of Immune-Related Cholangiopathies—A Critical Overview. Nutrients 2023; 15(3): 760 doi: 10.3390/nu15030760
|
| 12 |
Xingcan Fan, Anqi He, Kaiyu Li, Maorun Zhang, Qi Zhang, Wanyi Xiao, Gang Liu. The causal impact of genetically predicted inflammatory bowel disease on extraintestinal manifestations: a mendelian randomization study. BMC Gastroenterology 2025; 25(1) doi: 10.1186/s12876-024-03566-4
|
| 13 |
Isa Seida, Maisam Al Shawaf, Naim Mahroum. Fecal microbiota transplantation in autoimmune diseases – An extensive paper on a pathogenetic therapy. Autoimmunity Reviews 2024; 23(7-8): 103541 doi: 10.1016/j.autrev.2024.103541
|
| 14 |
Jikang Zhang, Yiqi Hu, Jin Xu, Hua Shao, Qingping Zhu, Hao Si. Genetically predicted immune cells mediate the association between gut microbiota and autoimmune liver diseases. Frontiers in Microbiology 2024; 15 doi: 10.3389/fmicb.2024.1442506
|